Targeting Cancer Stem Cells with RNAi

Researchers at the University of Central Florida are developing RNA interference (RNAi)-based therapies for increasing the sensitivity of cancer stem cells to chemotherapy. Cancer stem cells are a specialized subset of tumor cells that are often resistant to cancer therapy. This technology targets the expression of the embryonic stem cell genes NANOG or OCT4 which are expressed in cancer stem cells, but not in healthy adult cells. Technical Details This technology downregulates the expression of NANOG or OCT4 using gene silencing molecules such as short hairpin RNA (shRNA) and small interfering RNA (siRNA). Targeting these genes increased cell death in cancer stem cells treated with the chemotherapy drug, Temozolomide in vitro. The gene silencing molecules may be delivered by exosomes, which are endogenous molecules, to limit immunogenicity and toxicity. Brion Berman 407.882.0342

Related Blog

Smart, interactive desk

Get ready to take your space management game to the next level with the University of Glasgow’s innovative project! By combining the

Mechanical Hamstring™

University of Delaware Technology Overview This device was created to allow athletes who suffer a hamstring strain to return to the field

Join Our Newsletter

                                                   Receive Innovation Updates, New Listing Highlights And More